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SummAry
migrainous headache is determined by pathogenetic mechanisms that are also able to affect the peripheral and/or central vestibular system, 
so that vestibular symptoms may substitute and/or present with headache. We are convinced that there can be many different manifestations 
of vestibular disorders in migrainous patients, representing true different clinical entities due to their different characteristics and temporal 
relashionship with headache. Based on such considerations, we proposed a classification of vertigo and other vestibular disorders related to 
migraine, and believe that a particular variant of migraine-related vertigo should be introduced, namely “epigone migraine vertigo” (EmV): 
this could be a kind of late migraine equivalent, i.e. a kind of vertigo, migrainous in origin, starting late in the lifetime that substitutes, as 
an equivalent, pre-existing migraine headache. To clarify this particular clinical picture, we report three illustrative clinical cases among 
28 patients collected during an observation period of 13 years (november 1991 - november 2004). For all patients, we collected complete 
personal clinical history. All patients underwent standard neurotological examination, looking for spontaneous-positional, gaze-evoked and 
caloric induced nystagmus, using an infrared video camera. We also performed a head shaking test (hST) and an head thrust test (hTT). 
ocular motility was tested looking at saccades and smooth pursuit. To exclude other significant neurological pathologies, a brain magnetic 
resonance imaging (mri) with gadolinium was performed. During the three months after the first visit, patients were invited to keep a 
diary noting frequency, intensity and duration of vertigo attacks. After that period, we suggested that they use prophylactic treatment with 
flunarizine (5 mg per day) and/or acetylsalicylic acid (100 mg per day), or propranolol (40 mg twice a day). All patients were again recom-
mended to note in their diary the frequency and intensity of both headache and vertigo while taking prophylactic therapy. Control visits 
were programmed after 4, 12 and 24 months of therapy. All patients considerably improved symptoms with therapy: 19 subjects (68%) 
reported complete disappearance of vestibular symptoms, while 9 (32%) considered symptoms very improved. The subjective judgement 
was corroborated by data from patients diaries. We conclude that EmV is a clinical variant of typical migraine-related vertigo: a migraine-
associated vertigo, headache spell independent, following a headache period, during the lifetime of a patient.
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riASSunTo
La cefalea emicranica è determinata da meccanismi patogenetici che possono interessare anche il sistema vestibolare, periferico e/o cen-
trale, quindi la sintomatologia vestibolare può sostituire e/o manifestarsi insieme alla cefalea. Nei pazienti emicranici ci possono essere 
diverse manifestazioni di natura vestibolare, che rappresentano delle vere entità cliniche, diverse tra loro per le differenti caratteristiche 
e relazioni temporali con la cefalea. Su questa base abbiamo proposto una classificazione dei disturbi vestibolari correlati all’emicrania, 
e tra questi dovrebbe essere introdotta una variante particolare, la “vertigine emicranica epigona” (VEE): questa potrebbe essere un 
equivalente emicranico tardivo, cioè una vertigine di origine emicranica, che comincia tardivamente nella vita e che sostituisce, come 
equivalente, una cefalea emicranica preesistente. A questo proposito, riportiamo tre casi esemplificativi, scelti tra 28 pazienti selezionati 
durante un periodo di 13 anni (novembre 1991 – novembre 2004). Per tutti i pazienti è stata raccolta una dettagliata storia clinica. Tutti 
sono stati sottoposti ad un esame otoneurologico standard, per la ricerca del nistagmo spontaneo-posizionale, evocato da manovre oculari 
e provocato da stimolazione termica, usando una video-camera a raggi infrarossi. Abbiamo eseguito anche un head shaking test (HST) 
e un head thrust test (HTT). E’ stata valutata l’oculomotricità, con lo studio dei saccadici e dello smooth pursuit. Per escludere altre pa-
tologie neurologiche, è stata effettuata una risonanza magnetica nucleare (RMN) dell’encefalo con gadolinio. Durante i tre mesi dopo la 
prima visita, i pazienti sono stati invitati a compilare un diario, annotandovi la frequenza, l’intensità e la durata degli attacchi vertiginosi. 
Al termine di tale periodo, gli abbiamo consigliato di usare una terapia di profilassi con flunarizina (5 mg/die) e/o acido acetilsalicilico 
(100 mg/die), o con propranololo (40 mg x 2/die). Ancora una volta, abbiamo chiesto ai pazienti di annotare sul loro diario la frequenza e 
l’intensità sia della vertigine che della cefalea durante il trattamento. Le visite di controllo sono state programmate a 4, 12 e 24 mesi dall’i-
nizio della terapia. In tutti i pazienti si è avuto un miglioramento considerevole della sintomatologia: 19 soggetti (68%) hanno riportato la 
scomparsa completa della sintomatologia vestibolare, mentre 9 (32%) consideravano i loro sintomi notevolmente migliorati, anche se non 
completamente risolti. Il giudizio soggettivo era supportato dai dati ricavati dai diari dei pazienti. Possiamo concludere che la VEE è una 
variante clinica della vertigine correlata all’emicrania: una vertigine emicranica, indipendente dalle crisi algiche, che segue il periodo 
della cefalea, nel corso della vita del paziente. 
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Acta Otorhinolaryngol Ital 2014;34:62-70
62
EMV: a late migraine equivalent
63
Introduction 
Headache and vertigo are both very common complaints 
among internal medicine, neurological and neuro-otolog-
ical patients; nevertheless, the frequency of the clinical 
association of vertigo and headache among migraine pa-
tients is too high to be justified only by chance  1. It is 
a common opinion 2 that migrainous headache is deter-
mined by pathogenetic mechanisms that are also able to 
affect peripheral and/or central vestibular structures: the 
consequence is that vestibular disturbances may substitute 
and/or present with headache. 
Therefore, the hypothesis that migraine vertigo (MV) 
may be a real clinical entity seems, by now, confirmed 3. 
In fact, during the last decades some sorts of vertigo and 
dizziness associated with clinical syndromes typical of 
migrainous patients have been identified.
In 1961 Bickerstaff 4, for first, collected a series of young 
females complaining of vertigo, staggering and gait ataxia 
associated with other neurological disturbances like dys-
arthria, visual symptoms in both eyes, acroparesthesia, 
cranial nerve impairment and altered sensorium. In such 
a group of patients, the latter symptoms were followed 
by severe, occipital, throbbing headache associated with 
vomiting. This particular clinical picture was called “basi-
lar artery migraine”: it is the expression of functional dis-
turbance of the brainstem, cerebellum and occipital cortex 
as a probable effect of a transient ischaemia in the distri-
bution area of the basilar artery in migrainous subjects. 
Basser, in 1964  5, detected a kind of vertigo, typical of 
childhood, that he named “benign paroxysmal vertigo of 
childhood”. It is characterized by sudden, recurrent brief 
vertigo attacks associated with nausea and pallor making 
the patient unable to move, with a serious inability to stand. 
Vertigo attacks are not associated with headache or impair-
ment of consciousness. Paediatric patients usually have a 
clear family history for migraine and often develop true 
migraine headache after adolescence. Precocious vestibu-
lar symptoms are therefore considered as “precursors” of a 
migrainous headache (precocious canalar equivalent).
A similar manifestation is “ benign torticollis of infancy”, 
a clinical picture described by Snyder in 1969 6, that de-
velops during the first four years of life in some subjects 
with a clear family history of migraine. This manifesta-
tion seems to represent a “crisis” of the otolithic system 
induced by biochemical mechanisms of migrainous origin 
(precocious otolithic equivalent). 
In 1979, Slater 7 described a “benign recurrent vertigo of 
adults”, a vestibular syndrome characterized by recurrent 
spells of sudden and intense vertigo or unsteadiness as-
sociated with vagal symptoms. Such vertigo attacks occur 
in adults with migraine alternating with headache spells. 
In such patients, therefore, vertigo substitutes headache 
as migraine without headache, as described by Whitty 8, 
during the florid period of recurrent painful spells.
The International Headache Society (IHS), in the clas-
sification of the “ad hoc committee” of 1988 9, took in 
account the practical issue of “migraine related vertigo”. 
Vestibular disturbances occurring in patients suffering 
from migraine are separated in two groups: neuro-otolog-
ical disorders that are “due” to migraine and those that are 
“associated” with it. The first group includes: (1) benign 
paroxysmal torticollis of infancy, (2) benign paroxysmal 
vertigo in childhood, (3) basilar artery migraine, (4) be-
nign recurrent vertigo in adults and (5) migrainous infarct 
resulting in vertigo. The second group includes: (1) mo-
tion sickness, (2) Menière’s disease and (3) benign par-
oxysmal positional vertigo. On the other hand, both the 
IHS and the international literature did not overcome this 
simple subdivision and did not propose an actual classi-
fication of vestibular symptoms that can occur in persons 
with migraine. In the IHS classification of 2004 10 11 only 
two vestibular syndromes are listed: basilar type migraine 
and benign paroxysmal vertigo of childhood.
We are convinced that there are many different manifes-
tations of vestibular disorders in patients with migraine, 
representing true different clinical entities due to their 
different characteristics and temporal relationship with 
headache. Based on such characteristics, our group has 
proposed a classification of vertigo and other vestibular 
disorders related to migraine 12. Based on clinical expe-
rience acquired while evaluating and treating vestibular 
disorders occurring in patients with migraine, we believe 
that a particular variant of migraine-related vertigo should 
be introduced.
In November 1993, a woman affected by migraine without 
aura that suffered by intense and frequent headache spells 
since many years came to our attention. She referred that, 
during her lifetime, headaches began to decrease, while 
recurrent vertigo developed. In the patient’s history, the 
temporal sequence of the two symptoms was so striking 
that it came to our immediate attention. During the fol-
lowing years, we encountered other patients complaining 
of recurrent vertigo after a period of headache had ceased, 
or that headache was markedly decreased in frequency 
and intensity. 
To obtain a group of patients that was as clinically homo-
geneous as possible, we adopted rigorous selection crite-
ria to include such patients in our case study. 
The similarity of temporal succession of symptoms, ty-
pology of headache and vertigo spells, habitus, absence 
of any other definite vestibular pathology and negativity 
of general and neurological investigations that we noticed 
among our patients, lead us to consider such patients ho-
mogeneous enough to be grouped into a new nosological 
entity that we called “Epigone migraine vertigo” (EMV), 
from “epigonous” a term that means “borne after”.
Such a pathology could therefore represent a type of late 
migraine equivalent that can be defined as a “recurrent 
vestibular disorder occurring in migrainous subjects, ap-
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pearing late in their lives, substituting headache spells 
when the latter disappear or considerably reduce in fre-
quency and strength, when (for women) patients are still 
in their fertile age or sometimes at menopause”. 
To clarify this particular clinical picture we report three 
illustrative clinical cases.
Case 1: GS, female, 41 years old, date of visit 10.02.1995
Motion sickness since the age of 4 years, partially im-
proved after puberty. Springtime vasomotorial rhinitis. 
No general disorders in personal pathological history. 
Mother and grandmother with migraine without aura, ma-
ternal aunt with migraine with aura.
Headache. Migraine headache without aura since the age 
of 20 years. Acute headache spells lasting from 3 to 8 
hours, often throbbing, unilateral, with periorbital pain, 
always with phono/photophobia and nausea. Frequency: 
3-5 episodes each month, always during pre-menstrual 
period. Headache got only partially better using com-
mon analgesics, more often ceasing spontaneously with 
sleep. Maximal intensity and frequency between 20 and 
25 years. When the patient was 28, at the time of her first 
pregnancy, her headache completely disappeared. 
Vertigo. Immediately after her pregnancy, during the 13 
years before the visit, the patient started complaining of 
postural disturbances associated with instability in the up-
right position and nausea; each episode lasted from 6 to 
48 hours, had an acute onset and a complete resolution, 
without any residual symptoms. Frequency: 2-4 episodes 
each year. During the month prior to the visit she had 5 
episodes of imbalance, associated with nausea and vomit-
ing and inability to stand, lasting 6-12 hours. Such epi-
sodes were just a little bit shorter but more intense than 
the former, and symptoms were worsened by any move-
ment. Postural symptoms often improved with sleep. She 
came to visit because of worsening of symptoms.
Investigations. Cerebral magnetic resonance imaging 
(MRI), high resolution computed tomography (CT) 
scan, epiaortic Doppler sonography, electroencephalo-
gram (EEG) and serologic tests were normal as were 
audiometric, vestibular and neurological exams. Audio-
logical and vestibular tests remained negative during the 
follow-up period.
Therapy. Vestibular symptoms completely disappeared 
using migraine prophylactic drugs (acetylsalicylic acid 
100 mg plus flunarizine 5 mg per day) during 4 years fol-
low up. 
Comments. Patient suffers from migraine without aura 
with high familial history. Headache disappeared with 
pregnancy and vestibular symptoms (imbalance and sub-
jective rotatory vertigo) started immediately after it. The 
nine months of pregnancy represent, therefore, the free 
interval during which both symptoms were absent. After 
this period, migraine headache evolved into migraine-as-
sociated vertigo (late equivalent). Absence of other defi-
nite vestibular pathologies that could explain symptoms, 
negativity of audio-vestibular investigations and disap-
pearance of symptoms with migraine prophylaxis con-
firmed diagnosis of EMV. 
Case 2: ER, female, 47 years old, date of visit 24.03.1995
Motion sickness started during early childhood, hypoten-
sion since adolescence; no other significant subsequent 
pathology. Mother and maternal aunt suffered from mi-
graine without aura; a son who suffered from paroxysmal 
torticollis of infancy at the age of 28 months. 
Headache. Migraine headache since the age of 10 years; 
acute, throbbing headache crisis, with phono/photophobia 
and vomiting. Headache worsened with physical activity, 
it was rarely unilateral, it lasted from 2 to 48 hours and the 
maximal frequency of spells (2-3 per week) was between 
the age of 20 and 30 years. Only few episodes were pre-
ceded by visual aura involving both eyes (scotomata and 
flickering lights). Since June 1992 headaches became mild-
er, very rare, only sometimes related with menstrual cycle.
Vertigo. July 1992: first rotational vertigo with vomiting 
and inability to stand, lasted 10 hours, started acutely and 
rapidly ceased without signs. A similar rotational attack, 
6 hours long, occurred one month later. Since September 
1992, 2-4 episodes per month of marked dizziness associ-
ated with nausea and intolerance to standing, lasting from 
2 to 4 hours. Nearly half of vestibular crises were pre-
ceded by visual aura lasting 10-15 minutes. 
Investigations. Cerebral MRI, epiaortic colour Doppler 
sonography, EEG and serological tests were normal. Neu-
rologic examination and audiometry were normal. First 
vestibular testing showed a small amplitude down-beating 
nystagmus that was more pronounced in the sitting posi-
tion. With the patient on a left lateral position, there was 
a small amplitude, persistent, right beating nystagmus. 
During follow up, after therapy, down-beating nystagmus 
was even less pronounced, while right-beating positional 
nystagmus disappeared. 
Therapy. During 2 years prophylactic treatment with ace-
tylsalicylic acid 100 mg plus flunarizine 5 mg, daily, re-
current postural disturbance was no longer present.
Comments. Patient had migraine with aura (fulfilling IHS 
criteria) with a clear familial component. She did not suf-
fer from any other otologic or general pathology. Vestibular 
disturbances appeared immediately after the headache pe-
riod was almost completely over; between the two symp-
toms there was no, therefore, any free interval. It has to be 
remarked that visual aura was more frequent before vertigo 
than before headache. Using migraine prophylactic treat-
ment, dizziness and postural instability disappeared.
Case 3: AMG, female, 45 years old, date of visit 18.07.1996
Two normal pregnancies in patient’s history; marked mo-
tion sickness during childhood; hypotension, as a current 
general pathology. Father suffering from migraine with 
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aura, paternal grandmother and a daughter suffering from 
migraine without aura. 
Headache. Since puberty the patient suffered from mi-
graine headache, often intense, unilateral and with a 
periorbital localization; pain was throbbing, accompa-
nied by nausea and photophobia, exacerbated by physi-
cal activity.
Headache spells lasted 5-6 hours and were resistant to 
common analgesics, sometimes withdrawing with vomit-
ing. When headache occurred during the menstrual period 
it was associated with bilateral aural fullness and tinnitus. 
Only a few headache spells lasted more than 12 hours. 
Frequency of attacks: 1-3 episodes each month. Only be-
tween the ages of 19 and 25 years did the patient have 
more than one spell per month. Eighteen months before 
the visit, at the beginning of the menopausal period, the 
patient referred a gradual reduction of headache intensity 
and frequency, until its disappearance.
Vertigo. Since 18 months, patient suffered from rotational 
vertigo that, during the first 3 months, were of the sub-
jective type, associated with nausea and lasted from 30 
min to 2 hours; vertigo spells occurred more than once 
a week and were followed by light and diffuse headache 
that could last many hours.
Investigations. Cerebral MRI with gadolinium, colour 
Doppler sonography, serological tests, neurologic exami-
nation were negative. Audiometry and vestibular exams 
were normal both at the first visit and during the follow-
up period.
Therapy. During 3 years of prophylactic treatment with 
flunarizine 5 mg BID (she did not receive acetylsalicylic 
acid because of gastric intolerance) vestibular symptoms 
practically disappeared; only a light and rare sense of in-
stability, during the menstrual period, persisted. 
Comments. Patient suffered from migraine without aura 
and had a clear familial component for migraine. She 
did not suffer from any definite vestibular pathology that 
could explain vestibular symptoms. Headache gradually 
decreased at the beginning of the menopausal period, with 
the appearance of vestibular disturbances. Only during the 
first three months from the appearance of vertigo were 
vestibular symptoms followed by light headache. After-
wards, with the worsening of vertigo, the residual head-
ache disappeared. Both headache and vertigo improved 
with vomiting. The effectiveness of prophylactic treat-
ment confirmed a diagnosis of EMV. 
Materials and methods
To have a higher probability to include in our case study 
only patients suffering from migraine-related vertigo, we 
adopted the following selection criteria:
1. subject suffering from migraine as identified by IHS 
criteria;
2. recurrent vertigo and/or postural disturbances;
3. onset of vestibular symptoms after the disappearance 
(or remarkable reduction) of headache;
4. absence of audiologic and vestibular symptoms and 
signs having reference to definite neuro-otological pa-
thologies;
5. negative neurological examination and cerebral MRI;
6. absence of any vascular pathology or vascular risk fac-
tor;
7. effectiveness of migraine prophylactic treatment (dis-
appearance or marked reduction of vestibular symp-
toms);
8. at least 2 years of follow-up.
Considering these standards for inclusion, we collected 28 
patients during an observation period of 13 years, roughly 
November 1991- November 2004.
Inclusion criteria and purpose of the study were already 
determined since the first cases, and were maintained 
during the entire collection period. Therefore, our study 
was prospective. We collected a homogeneous group of 
patients sharing some characteristics that are specific for 
such a pathology.
The strict selection criteria allows us to affirm that pa-
tients with a different vestibular pathology would not have 
been included in the present case study. 
For all patients we collected complete personal clinical 
history, including family, remote and near pathological 
history. Particular attention was given in collecting the 
history regarding headache and vestibular disturbances.
We looked into the migrainous habitus searching for mi-
grainous manifestations in infancy (benign vertigo, par-
oxysmal torticollis and motion sickness). 
Firstly, we made us sure that patients suffered from head-
ache fulfilling migraine criteria as stated by the IHS. Af-
terwards, concerning headache, we determined: a) age of 
onset, duration and frequency; b) presence or absence of 
aura; c) family history.
Regarding vestibular symptoms, we determined: a) age 
of onset; b) type of vestibular symptom (rotational ob-
jective or subjective vertigo or postural troubles); c) du-
ration, intensity and frequency of spells; d) presence or 
absence of associated vagal symptoms; e) temporal trend 
of symptoms. 
Afterwards, we defined the temporal relationships between 
headache and vertigo periods over the patient’s lifetime; 
we asked patients to point out one of the following pos-
sible temporal relationships: a) between headache and ver-
tigo periods there was a symptom free interval; b) the two 
symptoms came one after the other, without any interval; c) 
vertigo gradually took place together with headache. More-
over, we asked to females if the passage of one symptom 
into the other coincided with the menopausal period. 
Furthermore, we asked all patients if at the time of the 
beginning of the period of vertigo their headache was: 
a) completely vanished; b) residual but reduced; c) only 
fairly reduced; d) nearly unchanged. 
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The persistence of a moderately reduced or unchanged 
headache lead us to exclude such patients from the study. 
Finally, during follow-up, we asked patients if, using 
prophylactic treatment, their vestibular symptoms were: 
a) completely vanished, b) residual but reduced; c) only 
fairly reduced; d) unmodified. The persistence of an un-
modified (or only partially reduced) vertigo led to exclu-
sion from the study.
We also asked patients if they had ever had audiological 
symptoms such as hearing loss, unilateral or bilateral tin-
nitus or fullness, together with vertigo or independently 
of from it.
Oto-microscopy was performed for all patients in addition 
to pure tone audiometry and impedance testing.
All patients underwent standard neurotological examina-
tion. Vestibular spontaneous-positional nystagmus was 
checked in seven positions (sitting, supine, right side, left 
side, head hanging, right and left Dix-Hallpike’s) using 
an infrared video camera. Gaze evoked nystagmus was 
also checked with the same modalities. Moreover, we per-
formed a head shaking test (HST) and a horizontal head 
thrust test (HTT) to test vestibulo-ocular reflex (VOR) to 
higher frequencies with respect to caloric stimuli.
Caloric induced nystagmus was investigated using 
Fitzgerald-Hallpike’s technique. To calculate labyrinthine 
and directional preponderance, we applied Jongkeens’ 
formulae considering, as a reference parameter, the slow 
phase angular velocity of caloric-induced nystagmus. 
Reference normative data were those indicated by Ba-
loh  13. Ocular motility was tested looking at horizontal 
and vertical saccades velocity, accuracy and latency and 
horizontal and vertical smooth pursuit gain 14. Both ocular 
motility and caloric nystagmus were recorded using com-
puted electronystamography.
All patients underwent a neurological visit to exclude oth-
er significant neurological pathologies that could justify 
both headache and vertigo. Moreover, for all patients, we 
carried out haematological workup, especially concerning 
vascular risk factors, as well as colour Doppler sonogra-
phy of carotid and vertebral arteries and brain MRI with 
gadolinium.
During the three months after the first visit, patients were 
asked to keep a diary noting frequency, intensity and du-
ration of vertigo attacks. In case of crises they should use 
only symptomatic drugs (antiemetics, anxiolytics).
After that period, we prescribed prophylactic treatment 
with flunarizine and acetylsalicylic acid. The suggested 
doses for flunarizine and acetylsalicylic acid were, re-
spectively, 5 mg and 100 mg per day.
If patients could not take acetylsalicylic acid for a gastric 
or other pathology, they were prescribed only flunarizine 
at 10 mg per day. On the other hand, if patients had some 
contraindications to flunarizine (obesity, depression) and/
or significant side effects (i.e. drowsiness), they were 
treated only with acetylsalicylic acid at 100 mg BID. 
Moreover, if patients could not take either drug, we pre-
scribed, as prophylactic therapy, propranolol at 40 mg BID.
All patients were again asked to record in their diary the 
frequency and intensity of both headache and vertigo 
while taking prophylactic therapy.
Control visits were programmed after 4, 12 and 24 months 
of therapy. Informed consent was obtained from all pa-
tients.
Results
Subjects
Our case study of patients affected by EMV includes 28 
subjects (23 females and 5 males): their mean age, at the 
first visit to our clinic, was 43 years, with a minimal age 
of 18 and a maximal age of 64 (SD: 11.9, mode: 45). The 
mean age at the onset of headache was 18 years (min: 8, 
max: 38; SD 7.4, mode 15); the mean age at the onset of 
vestibular symptoms was 38 years (min: 16; max 55; SD: 
11, mode: 46). Thus, EMV occurs after a mean headache 
period of 20 years. In more of 70% of patients vertigo 
started between 26 and 46 years, but among them, in half 
of cases, its onset peak is concentrated into the fourth dec-
ade (40-46 years). There was no difference between fe-
males and males concerning the age of onset of headache 
and vertigo or the interval between the periods of the two 
symptoms.
Headache
Twenty-two patients (78%) had migraine without aura 
and 6 (22%) suffered from migraine with aura. No pa-
tient suffered from any other type of migraine included in 
the definitions of the IHS. Among the 6 patients affected 
by migraine with aura, in one patient visual aura antici-
pated EMV spells more often than those of headache. In 
another patient migraine with aura first changed into mi-
graine without aura (roughly along a period of 2 years) 
and was then substituted by EMV (without aura). Among 
the remaining 4 patients, as vertigo began headache dis-
appeared together with the aura in three, and it markedly 
decreased in one.
Twenty-two of 28 patients affirmed to have or to have had 
motion sickness during their lifetime, at least during in-
fancy. Twenty-five subjects out of 28 had a clear family 
history of migraine. 
Vertigo and dizziness
Vestibular disturbances in our patients were very differ-
ent in terms of type, duration and frequency. We found 
that patients suffered both from objective and subjec-
tive rotational vertigo and postural imbalance. Vestibular 
symptoms were very different among subjects, while in 
the same patient they presented more similar in terms of 
quality, varying only in duration and intensity. In fact, 17 
patients (61%) always reported the same type of vertigo: 
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10 subjects (36%) had only objective rotational vertigo, 
4 (14%) had only postural disturbances and 3 (11%) had 
only subjective crises of rotational vertigo. In the remain-
ing 11 patients (39%), at least two types of vestibular 
symptoms were associated; only in three patients did ves-
tibular disturbances manifest with all the three kinds of 
vestibular symptoms (objective and subjective vertigo and 
postural disturbance). In any case, objective rotational 
vertigo, alone or associated, was referred by more than 
half of patients: in fact, true objective vertigo was report-
ed by 18 patients: vertigo alone, in 10 patients, vertigo 
alternating with subjective crises or postural imbalance, 
was seen in 8 subjects. 
The duration of the individual crisis was highly variable 
(Fig. 1): objective vertigo lasted, on the average, 15 hours 
(min 1/2 hour - max 3 days), while postural disturbances 
usually were longer, with a mean duration of 73 hours 
(min 1 hour – max 10 days). The mean duration of pos-
tural spells was reached by only a few subjects who had 
particularly prolonged crises. In individual patients also, 
duration of crises was variable, and was always shorter 
for objective spells compared to subjective ones. Accom-
panying vagal symptoms were present in all patients to-
gether with stronger crises; they were less severe in 11 
patients (only nausea) and more pronounced (nausea and 
vomiting) in 18 of the 28 subjects.
Almost all patients reported that head movements wors-
ened both vestibular and neurovegetative symptoms. Most 
patients returned to a relative well-being after the attack 
had ceased; a few subjects (7 of 28) had transient residual 
unsteadiness for a few days.
The mean frequency of spells (considering period of 
maximum incidence) varied from a minimum of one cri-
sis every 6 months to a maximum of 5 spells each month.
Only 2 patients were diagnosed as having a possible 
vestibular migraine, whether the other 26 had a diag-
nosis of Menière’s disease, vestibular neuritis, benign 
paroxysmal positional vertigo and psychogenic verti-
go. Twenty of 28 patients complained of kinetosis dur-
ing adult life, childhood or both, and 17 suffered from 
hypotension. 
Headache versus vertigo
In our case studies, the shift of headache into vestibular 
symptoms, over a patient’s lifetime, occurred according 
to three different patterns (Fig. 2): 1) with a variable free 
interval from both symptoms; 2) headache shifted directly 
into vertigo without a free interval; 3) headache gradu-
ally changed into vertigo with a period during which both 
symptoms are present. 
Transition with a free interval was reported by 8 patients 
(28.5%); in one case, the free interval coincided with 
pregnancy and, in other two, with menopause. Twelve pa-
tients (43%) reported the second modality of transforma-
tion, i.e. direct transformation of headache into vertigo: in 
4 cases transformation occurred during menopause. Final-
ly, 8 patients (28.5%) referred the gradual shift of the two 
symptoms, sensing a partial overlap. These patients there-
fore noticed a gradual reduction of headache and, at the 
same time, the worsening of vestibular disturbances until 
there persistence (or clear prevalence) of vertigo. Half of 
these patients noticed that the shift of the two symptoms 
occurred during menopause. 
Among the 23 females in our case study, in 10 cases 
(43.5%) headache shifted into vertigo at menopause or 
immediately after it. In one case, such a shift occurred 
after pregnancy and in the remaining 12 cases (52%) it 
occurred during the fertile age. 
Residual headache
Once headache changed into ver-
tigo, 16 patients (57%) reported 
that headache completely ceased, 
while 12 subjects (43%) noticed 
substantial improvement of this 
headache (only a light headache 
often limited to menstrual period) 
that became a minor disturbance 
compared with vertigo.
It should be noted that while in 
the group of patients with gradual 
transformation of the two symp-
toms, a light headache was still 
present in 6 of 8 subjects; in the 
group of patients with a symp-
tom-free interval, such a residual 
symptom was present in only 6 of 
20 cases.
Fig. 1. Reported duration of vestibular crisis in our case study: for each patient, the mean duration of pos-
tural disturbances (black histogram) and objective vertigo (dotted histogram) is given.
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Audiological symptoms
Bilateral (6) or unilateral (2) fullness was reported by 8 
patients, during almost all vertigo attacks; these symp-
toms ceased as vertigo disappeared. Five patients re-
ported tinnitus that also continued after a vertigo spell 
in only one case. Three patients had associated tinnitus 
and fullness. 
Audiometry and impedance testing
Twenty-one of 28 patients had normal audiometric and 
impedance exams. Three subjects had mild conductive 
hearing loss (1 tympanosclerosis, 2 myringosclerosis) 
and three had a high frequency sensorineural hearing 
loss. 
Vestibular testing
Only 4 patients had a spontaneous-positional nystagmus. 
One patient, at the first visit, had a pluri-positional down-
beating nystagmus associated with a right-beating nystag-
mus in the left lateral position: at follow-up visits, during 
prophylactic treatment, right horizontal nystagmus disap-
peared while down-beating nystagmus remained, even if 
reduced in amplitude. One patient had down-beating nys-
tagmus in all clinical positions that remained unchanged 
during follow-up. Another subject had a slight geotropic, 
persistent nystagmus on the left and right lateral posi-
tions: this sign disappeared after one year of follow-up 
(this patient also had unilateral labyrinthine weakness). 
One patient had a horizontal spontaneous left beating nys-
tagmus only on the right lateral position that decreased 
in amplitude with time. Moreover, during caloric tests 19 
patients (68%) showed a significant vagal reaction with 
nausea and vomiting. Only one patient had a unilateral 
labyrinthine failure (associated with a spontaneous nys-
tagmus of the central type) and one subject had unilateral 
labyrinthine weakness, without spontaneous-positional 
nystagmus. None of our patients was evaluated during the 
acute phase of vertigo.
Pharmacological prophylaxis
All 28 patients were treated using a prophylactic regimen: 
22 took acetylsalicylic acid 100 mg per day and flunar-
izine 5 mg per day; 3 patients took propranolol 40 mg 
BID, because of contraindication to both acetylsalicylic 
acid and flunarizine; 3 patients took only flunarizine at a 
dose of 5 mg BID because of contraindication to acetyl-
salicylic acid. 
Symptoms considerably improved in all patients with 
therapy (failed improvement was an exclusion criteria). 
Nineteen subjects (68%) reported the complete disappear-
ance of vestibular symptoms, while 9 (32%) considered 
their symptoms very much improved even if not com-
pletely resolved.
Subjective judgement was corroborated by data extracted 
from diaries during the three months before and after the 
beginning of prophylactic therapy. Four patients were ex-
cluded from the case series due to unsatisfactory response 
to therapy (therapeutic failure was considered as a marker 
of a diagnostic error).
Discussion and conclusions
In the literature there is no mention of the existence of a 
structured survey of EMV: a type of vertigo, migrainous 
in origin, starting late in lifetime that substitutes, as an 
equivalent, a pre-existing migrainous headache. On the 
other hand, several authors have noted that some migraine 
patients, suffering from headache in a young or adult age, 
also suffered from recurrent vertigo later in their lives. 
In 1985, Hood and Kayan 15 stated: “we have recently 
seen a number of patients at the National Hospital Queen 
Square of London, whose migrainous attacks ceased af-
ter middle age, giving way to recurrent attacks of ver-
tigo”. A belated transformation of headache into vertigo 
in migrainous women at menopause was also reported by 
Harker in 1996 16; the author wrote: “many older women, 
who had severe migraine headache earlier in their lives 
that had become much milder after menopause, postmen-
opausally, however, begin to experience episodic vertigo, 
sometimes with accompanying mild headache”.
Similarly, in 1961 Atkinson 17 observed a temporal rela-
tionship between migraine headache and Menière’s dis-
ease: “a frequent story told by the Menière’s patient is 
that he suffered from migraine all his life, but that when 
the dizzy attacks began, his headache ceased”. Such a cor-
relation was confirmed by Toglia in 1981 18: “attacks of 
vertigo typical of Menière’s disease may replace, usually 
later in life, the attacks of migraine”.
Even if occasional and brief, these literature annotations 
prompted us to look for such patients in daily clinical 
Fig. 2. Headache vs. vertigo: patterns of transitions of the two symptoms 
over the course of a lifetime. Height and width of triangles indicate, respec-
tively, the strength and duration of headache or vertigo spells.
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activity: subjects suffering from vestibular migraine in 
which vertigo could represent a late equivalent of their 
migraine headache. The first patient satisfying these crite-
ria was found in November 1993. 
Examining the previous reports of patients in our survey, 
not only was no temporal relationship noted between 
headache and vertigo, but a diagnosis of vestibular mi-
graine was not presumed in 26 of 28 cases. 
The extended suffering of these patients lead us to two 
considerations: 1) the diagnosis of vestibular migraine is 
too often neglected by general practitioners and, some-
times, by neuro-otologists as well; 2) patients with vestib-
ular migraine do not have improvement of symptoms with 
drugs other than those indicated in migraine prophylaxis.
Therefore, also for EMV, we agree with Dieterich and 
Brandt 19 when they state that in subjects suffering from 
vestibular migraine there are “difficulties in defining the 
disease and frustrating attempts to treat these patients”. 
During 9 years of EMV case selection, we never encoun-
tered patients suffering from any type of primary head-
ache (cluster, tension or occasional headache) other than 
migraine and whose vestibular symptoms manifested in 
substitution of headache. Hence, EMV could represent a 
typical manifestation solely of primary migraine head-
ache. 
Particularly interesting is the clinical fact that in spite of 
the long duration of vestibular symptoms before diagno-
sis (at least 10 years in 6 patients and three years in 16 
cases), none or our patients had another transformation of 
the vestibular disturbance into headache or into another 
migraine equivalent; therefore, vestibular symptoms of 
patients with EMV appear to represent the last delayed 
manifestation of their migrainous habitus. Hence, EMV 
does not seem to be a temporary conversion, but rather a 
definite conversion of migrainous symptoms. 
With the intent of comparing benign paroxysmal vertigo 
of childhood and EMV, we can affirm that the former is 
the first kind of migrainous vertigo that will often give 
rise, later, to migraine headache 20, whereas the latter is 
the last manifestation of a migrainous vertigo that will 
substitute migraine headache. Therefore, the two forms 
of vertigo could be, respectively, the first and the last mi-
graine equivalent, as shown in migraine classification that 
we proposed in 2003 12. 
In our EMV survey we collected 25 cases of migraine 
without aura and 3 with aura: such a distribution seems 
to represent the reported prevalence of the two forms in 
migraine population. Thus, the presence or absence of an 
aura does not seem to favour the evolution towards EMV.
Moreover, among our patients there was a clear preva-
lence of females over males, thus reflecting the female 
prevalence of migraine headache.
Ten of 23 females (43.5%) in our case study had trans-
formation of migraine headache into EMV during or im-
mediately after menopause; in the remaining 13 women, 
such a transformation manifested during the fertile age. 
Menopause therefore seems to be a facilitating and not a 
decisive factor for the transformation of migraine head-
ache into EMV. Almost all patients experienced recurrent 
attacks of vertigo, belatedly and unexpectedly manifested, 
as more severe and disabling than the previous headache.
In patients with EMV, current or pre-existing motion 
sickness, hypersensitivity to rapid head movements 
and an intense vagal reaction to vestibular instrumen-
tal stimuli (caloric and rotational) were very common 
complaints; they showed particular hypersensitivity 
and, consequently, intolerance to vestibular stimulation. 
When not experiencing a crisis, in spite of the large 
number of attacks of vertigo or postural disturbances 
that patients referred, neuro-otologic investigation was, 
very often, negative. 
Among our patients we found a remarkable polymor-
phism of vestibular symptoms (objective and subjective 
vertigo, dizziness); various types of symptoms were also 
reported also by the same patients in different occasions. 
Many of the characteristics of EMV are thus very similar 
to those reported by Dieterich and Brandt 19 for 90 pa-
tients with vertigo related to migraine. 
In young patients suffering from migraine, recurrent 
episodes of vertigo, both quantitatively and qualitatively 
polymorphic, also long-lasting and without associated 
relevant clinical cochleo-vestibular signs, diagnosis of 
migraine-associated vestibulopathy is very probable, in 
agreement with Baloh’s statement 21: “when recurrent at-
tacks begin at an early age in a patient with normal hear-
ing and migraine there are a few diagnosis other than mi-
graine that need to be considered”; the same consideration 
goes for EMV. 
We conclude that EMV is a clinical variant of typical 
migraine-related vertigo: a migraine-associated vertigo, 
headache spell independent, following the headache pe-
riod, over the course of a lifetime.
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